Based on the data, I would recommend a SELL. Here's a brief justification:

* The trailing and forward PEs are very high, indicating that the stock is overvalued.
* The ROE and profit margin are decent but not exceptional, which doesn't justify the high valuation.
* The revenue growth and earnings growth are both negative, indicating a slowdown in the company's growth prospects.
* The debt-to-equity ratio is relatively high, which may impact the company's financial health.

Overall, the stock appears to be overvalued and has poor growth prospects, which justifies a SELL recommendation.